Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 15Hodgkin Disease 13Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Leukemia, Biphenotypic, Acute 8Leukemia 8Burkitt Lymphoma 7Breast Neoplasms 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Mantle-Cell 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Triple Negative Breast Neoplasms 4Sarcoma 4Rhabdomyosarcoma 4Medulloblastoma 4Lymphoma, Follicular 4Anemia, Refractory, with Excess of Blasts 4Leukemia, Myelomonocytic, Chronic 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2

Interventions

Cyclophosphamide 49fludarabine 36Dexamethasone 35venetoclax 29pembrolizumab 26Rituximab 21Lenalidomide 18pomalidomide 17Gemcitabine 17fludarabine phosphate 15Etoposide 14Cytarabine 13daratumumab 11carfilzomib 11Temozolomide 11Cisplatin 10Calcium Dobesilate 10glofitamab 9Nivolumab 9Injections 9Azacitidine 9selinexor 8Vincristine 8Carboplatin 8Bortezomib 8obinutuzumab 7Immunotherapy, Adoptive 7Bevacizumab 7zanubrutinib 6ruxolitinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Filgrastim × 1 year × Clear all
NCT07257419 2026-05-19

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

St. Jude Children's Research Hospital

Phase 1 Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03263936 2025-10-16

Epigenetic Reprogramming in Relapse/Refractory AML

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
37 enrolled 11 charts
Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡